Meeting
2023 ASCO Annual Meeting
Pathway enrichment analysis in tumors with high mutation burdens and interferon-γ signature expression: A pancancer analysis.
Authors
Xuanyi Li
Vanderbilt University Medical Center, Nashville, TN
Xuanyi Li , Ben Ho Park , Justin M. Balko , Douglas Buckner Johnson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Tissue-Based Biomarkers
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3138)
DOI
10.1200/JCO.2023.41.16_suppl.3138
Abstract #
3138
Poster Bd #
336
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Effect of heterozygosity loss of HLA-I on immune evasion and promotion of non-small cell lung cancer brain metastasis and immunotherapy resistance.
First Author: Jiefei Han
Poster
2024 ASCO Annual Meeting
Characterization of T-cell receptor repertoire and correlation with tumor mutational landscape in lung cancer.
First Author: Wei Guo
Poster
2023 ASCO Annual Meeting
A novel platform to enrich for tumor-specific T cells in non–small-cell lung cancer.
First Author: Stephanie J Hachey
First Author: Stefan G van Ravensteijn